MECP2 Gene Angelman-like syndrome Genetic Test
Components: MECP2 Gene Angelman-like syndrome Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MECP2 Gene Angelman-like syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MECP2 Gene Angelman-like syndrome.
Test Details
The MECP2 gene Angelman-like syndrome NGS genetic test is a diagnostic test that analyzes the MECP2 gene for mutations or changes that may cause Angelman-like syndrome. Angelman-like syndrome is a rare genetic disorder that shares many of the clinical features of Angelman syndrome but is caused by mutations in different genes. The MECP2 gene provides instructions for making a protein that is essential for the normal development and function of the brain. Mutations in this gene can disrupt the production or function of the protein, leading to neurological problems and developmental delays.
NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the rapid and accurate analysis of DNA sequences. The MECP2 gene Angelman-like syndrome NGS genetic test uses this technology to analyze the entire coding region of the MECP2 gene, as well as nearby non-coding regions that may contain regulatory elements. The test can detect a wide range of mutations, including small deletions or insertions, single nucleotide changes, and larger structural variants.
The MECP2 gene Angelman-like syndrome NGS genetic test is typically ordered by a healthcare provider when there is suspicion of Angelman-like syndrome based on clinical symptoms. The test may also be recommended for individuals with a family history of the condition or for those who have previously tested negative for other genetic causes of Angelman-like syndrome. The results of the test can help confirm a diagnosis, guide treatment and management decisions, and provide information for genetic counseling and family planning.
| Test Name | MECP2 Gene Angelman-like syndrome Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MECP2 Gene Angelman-like syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MECP2 Gene Angelman-like syndrome |
| Test Details |
MECP2 gene Angelman-like syndrome NGS genetic test is a diagnostic test that analyzes the MECP2 gene for mutations or changes that may cause Angelman-like syndrome. Angelman-like syndrome is a rare genetic disorder that shares many of the clinical features of Angelman syndrome but is caused by mutations in different genes. The MECP2 gene provides instructions for making a protein that is essential for the normal development and function of the brain. Mutations in this gene can disrupt the production or function of the protein, leading to neurological problems and developmental delays. NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that allows for the rapid and accurate analysis of DNA sequences. The MECP2 gene Angelman-like syndrome NGS genetic test uses this technology to analyze the entire coding region of the MECP2 gene, as well as nearby non-coding regions that may contain regulatory elements. The test can detect a wide range of mutations, including small deletions or insertions, single nucleotide changes, and larger structural variants. The MECP2 gene Angelman-like syndrome NGS genetic test is typically ordered by a healthcare provider when there is suspicion of Angelman-like syndrome based on clinical symptoms. The test may also be recommended for individuals with a family history of the condition or for those who have previously tested negative for other genetic causes of Angelman-like syndrome. The results of the test can help confirm a diagnosis, guide treatment and management decisions, and provide information for genetic counseling and family planning. |
